CCR4 is detectable in almost all of the CTCL cases involving the blood using flow cytometry, and percentages of CCR4‐positive cells range from 31% to 97%. This evidence concerns the gene CCR4 and primary cutaneous T-cell non-Hodgkin lymphoma.